{"id":"W4401435959","doi":"10.1093/bjd/ljae266.067","title":"693 - Efficacy and safety of orismilast, a potent PDE4B/D inhibitor, in adults with moderate-to-severe atopic dermatitis: a phase 2b randomized, double-blind, placebo-controlled clinical trial (ADESOS)","year":2024,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Placebo; Atopic dermatitis; Internal medicine; Tolerability; Apremilast; Population; Clinical endpoint; Psoriasis; Randomized controlled trial; Gastroenterology; Clinical trial; Adverse effect; Immunology; Disease; Psoriatic arthritis; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002310304,0.001473142,0.002526054,0.0003505245,0.0003757415,0.0007841823,0.0005639978,0.001587682,0.008873611],"category_scores_gemma":[0.00114064,0.0005674514,0.001865802,0.0002717579,0.0006665514,0.0007237773,0.0002816651,0.001970296,0.001137197],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003573561,"about_ca_system_score_gemma":0.0007737778,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003049515,"about_ca_topic_score_gemma":0.0008742273,"domain_scores_codex":[0.9993868,0.0002997921,0.00006280736,0.000106873,0.00006477704,0.00007898579],"domain_scores_gemma":[0.9994211,0.0001361048,0.00015227,0.00003279678,0.00006663086,0.000191194],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9675651,0.009756155,0.001111208,0.0009028623,0.0007688097,0.00003923411,0.00003569636,0.0001416796,0.0051171,0.00006349526,0.0009266132,0.01357222],"study_design_scores_gemma":[0.8908549,0.1040516,0.003092303,0.00003951372,0.0004732189,0.00003620979,0.00001060067,0.0001808084,0.0004906117,0.00005864927,0.0007014105,0.00001010377],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9823664,0.006876163,0.0004611832,0.000583473,0.0004788367,0.004758602,0.001989127,0.0001042591,0.00238188],"genre_scores_gemma":[0.9829429,0.003323986,0.001882655,0.001399484,0.0006838939,0.004815492,0.001873236,0.00001860922,0.003059773],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008873611,"threshold_uncertainty_score":0.0296852,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01806843697846072,"score_gpt":0.3136291326597535,"score_spread":0.2955606956812928,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}